Wells Fargo’s PaxMedica, Inc. Common Stock PXMD Stock Holding History

Wells Fargo’s Portfolio PXMD Stock Details PXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30	Closed	-$15	–	7750
2024 Q1	$15	Buy	30 +28	+1,400%	+$16	﹤0.01%	7213
2023 Q4	$2	Hold	2	–	–	﹤0.01%	7553
2023 Q3	$10	Hold	2	–	–	﹤0.01%	7400
2023 Q2	$28	Buy	2 +1	+100%	+$25	﹤0.01%	7219
2023 Q1	$44	Hold	1	–	–	﹤0.01%	7145
2022 Q4	$45	Buy	+1	New	+$36	﹤0.01%	7051

Other funds holding PXMD

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo's PXMD Position: Q2 2024 in Review

Wells Fargo sold out of PaxMedica, Inc. Common Stock (PXMD) in Q2 2024, closing a stake of 30 shares — an estimated $15 sold.

Wells Fargo first reported a position in PXMD in Q4 2022 and held it in 6 quarters. The position peaked at $45 in Q4 2022. 1 fund tracked by Wall St. Rank holds PXMD as of Q2 2024.

Wells Fargo reported no remaining PaxMedica, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Wells Fargo sold 30 PaxMedica, Inc. Common Stock shares in Q2 2024, an estimated $15.
Wells Fargo first reported a position in PaxMedica, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
Wells Fargo's PaxMedica, Inc. Common Stock position peaked at $45 in Q4 2022.
1 fund tracked by Wall St. Rank held PaxMedica, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.